Congenital sideroblastic anemia associated with germline polymorphisms reducing expression of FECH

Haematologica

Volumn 93, Issue 10, 2008, Pages 1582-1584

  Caudill, Jonathan S ^a   Imran, Hamayun ^b   Porcher, Julie C ^a   Steensma, David P ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTOPORPHYRIN;

CASE REPORT; DNA DETERMINATION; DNA POLYMORPHISM; ERYTHROPOIESIS; GENE EXPRESSION; GERM LINE; HUMAN; LETTER; MALE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDEROBLASTIC ANEMIA;

ANEMIA, SIDEROBLASTIC; BASE SEQUENCE; CHILD, PRESCHOOL; FERROCHELATASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOME, HUMAN; GERM-LINE MUTATION; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 54349088475     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12597     Document Type: Letter

References (12)

1. Alcindor T, Bridges KR. Sideroblastic anaemias. Br J Haematol 2002;116:733-43.
2. Bottomley SS. Congenital sideroblastic anemias. Curr Hematol Rep 2006;5:41-9.
3. Steensma DP, Hecksel KA, Porcher JC, Lasho TL. Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts). Leuk Res 2007;31:623-8.
4. Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 2007;110: 4108-10.
5. Ferreira GC. Ferrochelatase. Int J Biochem Cell Biol 1999; 31:995-1000.
6. Rademakers LH, Koningsberger JC, Sorber CW, Baart de la Faille H, Van Hattum J, Marx JJ. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 1993;23:130-8.
7. Scott AJ, Ansford AJ, Webster BH, Stringer HC. Erythropoietic protoporphyria with features of a sideroblastic anaemia terminating in liver failure. Am J Med 1973;54:251-9.
8. Kushner JP, Cartwright GE. Sideroblastic anemia. Adv Intern Med 1977;22:229-49.
9. Rufenacht UB, Gouya L, Schneider-Yin X, Puy H, Schafer BW, Aquaron R, et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 1998;62:1341-52.
10. Di Pierro E, Brancaleoni V, Moriondo V, Besana V, Cappellini MD. Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria. Clin Genet 2007;71:84-8.
11. Schneider-Yin X, Gouya L, Meier-Weinand A, Deybach JC, Minder EI. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care. Eur J Pediatr 2000;159:719-25.
12. Phillips JD, Steensma DP, Pulsipher MA, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood 2007;109:2618-21.